Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 68

1.

CHALLENGES FACED IN TRANSFERRING ECONOMIC EVALUATIONS TO MIDDLE INCOME COUNTRIES.

Drummond M, Augustovski F, Kaló Z, Yang BM, Pichon-Riviere A, Bae EY, Kamal-Bahl S.

Int J Technol Assess Health Care. 2016 Feb 1:1-7. [Epub ahead of print]

PMID:
26831815
2.

[Cost-effectiveness of quadrivalent vaccine against human papilloma virus in Argentina based on a dynamic transmission model].

Pichon-Riviere A, Alcaraz A, Caporale J, Bardach A, Rey-Ares L, Klein K, Calderón M, Augustovski F, Tatti S.

Salud Publica Mex. 2015 Dec;57(6):504-13. Spanish.

3.

Resource Use And Costs of Congestive Heart Failure Hospitalizations: A Retrospective Cohort Study In Argentina.

Augustovski F, Caporale J, Fosco M, Alcaraz A, Diez M, Thierer J, Peradejordi M, Pichon Riviere A.

Value Health. 2015 Nov;18(7):A829. doi: 10.1016/j.jval.2015.09.307. Epub 2015 Oct 20. No abstract available.

PMID:
26534425
4.

An Eq-5d-5l Value Set Based On Uruguayan Population Preferences: Report Of The First Experience In Latin America.

Augustovski F, Rey-Ares L, Irazola V, Garay U, Gianneo O, Fernandez G, Morales MR, Gibbons L, Ramos-Goñi JM.

Value Health. 2015 Nov;18(7):A810-1. doi: 10.1016/j.jval.2015.09.104. Epub 2015 Oct 20. No abstract available.

PMID:
26534322
5.

Medical Devices - From Licensing To Coverage: Highlights From Argentina, Brazil, Colombia, And Mexico.

Rey-Ares L, Garay U, García-Martí S, Gilardino R, Cabra HA, Pichón-Riviere A, Augustovski F.

Value Health. 2015 Nov;18(7):A807. doi: 10.1016/j.jval.2015.09.086. Epub 2015 Oct 20. No abstract available.

PMID:
26534305
6.

The Efficiency Path: An Estimation of Cost-Effectiveness Thresholds for 185 Countries Based on Per Capita Health Expenditures and Life Expectancy.

Pichon-Riviere A, Augustovski F, Garcia Marti S, Caporale J.

Value Health. 2015 Nov;18(7):A695-6. doi: 10.1016/j.jval.2015.09.2592. Epub 2015 Oct 20. No abstract available.

PMID:
26533898
7.

Eliminating artificial trans fatty acids in Argentina: estimated effects on the burden of coronary heart disease and costs.

Rubinstein A, Elorriaga N, Garay OU, Poggio R, Caporale J, Matta MG, Augustovski F, Pichon-Riviere A, Mozaffarian D.

Bull World Health Organ. 2015 Sep 1;93(9):614-22. doi: 10.2471/BLT.14.150516. Epub 2015 Jun 23.

8.

Response to real-life decision-making impact of Oncotype DX.

Augustovski F, Soto N, Caporale J, Gonzalez L, Gibbons L, Ciapponi A.

Breast Cancer Res Treat. 2015 Nov;154(1):211. No abstract available.

PMID:
26475703
9.

Erratum to: An EQ-5D-5L value set based on Uruguayan population preferences.

Augustovski F, Rey-Ares L, Irazola V, Garay OU, Gianneo O, Fernández G, Morales M, Gibbons L, Ramos-Goñi JM.

Qual Life Res. 2016 Feb;25(2):335. doi: 10.1007/s11136-015-1146-9. No abstract available.

PMID:
26439111
10.

An EQ-5D-5L value set based on Uruguayan population preferences.

Augustovski F, Rey-Ares L, Irazola V, Garay OU, Gianneo O, Fernández G, Morales M, Gibbons L, Ramos-Goñi JM.

Qual Life Res. 2016 Feb;25(2):323-33. doi: 10.1007/s11136-015-1086-4. Epub 2015 Aug 5. Erratum in: Qual Life Res. 2016 Feb;25(2):335.

PMID:
26242249
11.

Correction: Oxytocin in Uniject Disposable Auto-Disable Injection System versus Standard Use for the Prevention of Postpartum Hemorrhage in Latin America and the Caribbean: A Cost-Effectiveness Analysis.

Pichon-Riviere A, Glujovsky D, Garay OU, Augustovski F, Ciapponi A, Serpa M, Althabe F.

PLoS One. 2015 Jul 15;10(7):e0133344. doi: 10.1371/journal.pone.0133344. eCollection 2015. No abstract available.

12.

Decision-making impact on adjuvant chemotherapy allocation in early node-negative breast cancer with a 21-gene assay: systematic review and meta-analysis.

Augustovski F, Soto N, Caporale J, Gonzalez L, Gibbons L, Ciapponi A.

Breast Cancer Res Treat. 2015 Aug;152(3):611-25. doi: 10.1007/s10549-015-3483-3. Epub 2015 Jul 1.

PMID:
26126971
13.

Oxytocin in Uniject Disposable Auto-Disable Injection System versus Standard Use for the Prevention of Postpartum Hemorrhage in Latin America and the Caribbean: A Cost-Effectiveness Analysis.

Pichon-Riviere A, Glujovsky D, Garay OU, Augustovski F, Ciapponi A, Serpa M, Althabe F.

PLoS One. 2015 Jun 9;10(6):e0129044. doi: 10.1371/journal.pone.0129044. eCollection 2015. Erratum in: PLoS One. 2015;10(7):e0133344.

14.

IMPLICATIONS OF GLOBAL PRICING POLICIES ON ACCESS TO INNOVATIVE DRUGS: THE CASE OF TRASTUZUMAB IN SEVEN LATIN AMERICAN COUNTRIES.

Pichon-Riviere A, Garay OU, Augustovski F, Vallejos C, Huayanay L, Bueno Mdel P, Rodriguez A, de Andrade CJ, Buendía JA, Drummond M.

Int J Technol Assess Health Care. 2015 Jan;31(1-2):2-11. doi: 10.1017/S0266462315000094. Epub 2015 May 20.

PMID:
25989703
15.

Reply to Roberts et al.: CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration.

Husereau D, Drummond M, Petrou S, Greenberg D, Mauskopf J, Augustovski F, Briggs AH, Moher D, Loder E, Carswell C.

Pharmacoeconomics. 2015 May;33(5):535-6. doi: 10.1007/s40273-015-0277-8. No abstract available.

PMID:
25893576
16.

The role of globalization in drug development and access to orphan drugs: orphan drug legislation in the US/EU and in Latin America.

Arnold RJ, Bighash L, Bryón Nieto A, Tannus Branco de Araújo G, Gay-Molina JG, Augustovski F.

F1000Res. 2015 Feb 27;4:57. doi: 10.12688/f1000research.4268.1. eCollection 2015.

17.

Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report.

Ramsey SD, Willke RJ, Glick H, Reed SD, Augustovski F, Jonsson B, Briggs A, Sullivan SD.

Value Health. 2015 Mar;18(2):161-72. doi: 10.1016/j.jval.2015.02.001. Review.

PMID:
25773551
18.

[High sensitivity C protein as an independent risk factor in people with and without history of cardiovascular disease].

Brito V, Alcaraz A, Augustovski F, Pichón-Riviere A, García-Martí S, Bardach A, Ciapponi A, Lopez A, Comandé D; Grupo de Evaluación de Tecnologías Sanitarias.

Arch Cardiol Mex. 2015 Apr-Jun;85(2):124-35. doi: 10.1016/j.acmx.2014.11.005. Epub 2015 Feb 18. Spanish.

PMID:
25700576
19.

Institutionalizing health technology assessment for priority setting and health policy in Latin America: from regional endeavors to national experiences.

Augustovski F, Alcaraz A, Caporale J, García Martí S, Pichon Riviere A.

Expert Rev Pharmacoecon Outcomes Res. 2015 Feb;15(1):9-12. doi: 10.1586/14737167.2014.963560. Epub 2014 Nov 25.

PMID:
25420744
20.

Comprehensive approach for hypertension control in low-income populations: rationale and study design for the hypertension control program in Argentina.

Mills KT, Rubinstein A, Irazola V, Chen J, Beratarrechea A, Poggio R, Dolan J, Augustovski F, Shi L, Krousel-Wood M, Bazzano LA, He J.

Am J Med Sci. 2014 Aug;348(2):139-45. doi: 10.1097/MAJ.0000000000000298. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk